Generic Drugmaker Expresses Interest In Latin America

CFW View: While Aspen Pharmaceuticals has shifted its focus away from its domestic market, we believe the company's continuing success depends on increasing expansion efforts in countries with an affinity for generic medicines. Deputy CEO of Aspen Gus Attridge has said his company has allocated upwards of US$800mn for future mergers and acquisitions. According to Reuters, the South African generic drugs manufacturer is looking to "further expand in fast-growing Latin America".

To read the full article, please choose one of the following options: